Legal Representation
Attorney
B. Brett Heavner
USPTO Deadlines
Next Deadline
1175 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-10-18)
Due Date
October 18, 2028
Grace Period Ends
April 18, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 7, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Mar 6, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Feb 10, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Feb 10, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Jan 18, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Oct 18, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Oct 18, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Aug 2, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 2, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 1, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Jul 13, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Jul 13, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Jul 13, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 24, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 18, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 17, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jun 17, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 16, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jun 16, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 16, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jun 16, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 16, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
May 24, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
May 21, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
May 5, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
May 5, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Mar 26, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Mar 25, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 31, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Aug 27, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 26, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin
Class 038
Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin
Class 042
Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; pharmaceutical research and development services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; scientific research for medical purposes in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of medical research, product development and scientific research in relation to skin diseases and treatment of the skin; pharmaceutical tests, namely, testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin
Class 044
Medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical tests, namely, medical testing for diagnostic or treatment purposes in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin
Additional Information
Design Mark
The mark consists of a tripartite swoosh design above the words "MY LEO PHARMA".
Pseudo Mark
MY LEO PHARMACY
Classification
International Classes
005
038
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"